We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name MTX@LNP, methotrexate lipid nanoparticles
Catalog Number R-C-00068
Alias MTX lipid nanocarriers
Appearance Milky white or light yellow semi-solid/liquid suspension
Molecular Formula N/A
Solubility Soluble in organic solvents
Storage -20°C, protected from light
Purity 95%+
Shelf Life 1 year
Shipping Condition low temperature transport
Application Nanomedicine Research
Specification 10mg：Inquiry
25mg：Inquiry
50mg：Inquiry
Description MTX@LNP, methotrexate (MTX)-loaded lipid nanoparticles (LNP), is an innovative drug delivery system. Lipid nanoparticles are composed of lipid components such as phospholipids and cholesterol. They have good biocompatibility and degradability and can efficiently encapsulate methotrexate in them. This combination overcomes the shortcomings of methotrexate such as poor water solubility, weak targeting, and high systemic harmfulness. Through targeted modification of lipid nanoparticles, the drug can be accurately delivered to diseased cells, increasing the drug concentration at the lesion site, while reducing distribution in normal tissues and reducing side effects. Currently, MTX@LNP shows great potential in the field of tumor treatment and autoimmune diseases. For example, in cancer treatment, it can enhance the killing effect on tumor cells; in rheumatoid arthritis treatment, it can act more accurately on the site of inflammation. However, its research and development and application are still in the exploratory stage, and there are problems such as complex preparation processes and high costs.
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Place the Order
FAQs
logo

Enter your email here to subscribe.

Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket